In clinical trials, retatrutide doses were increased every 4 weeks, as shown in the dosage chart above
Semi-automated selection of cryo-EM particles in RELION-1.3
Contraindications: Mechanical obstruction: should not be given to patients having any form of mechanical obstruction in the GI tract or bladder Compromised GI or Bladder Wall Integrity : should not be given to patients where the integrity of the gastrointestinal or bladder wall is in question Hypersensitivity to bethanechol chloride tablets, Hyperthyroidism Peptic ulcer Latent or active bronchial asthma, Pronounced bradycardia or hypotension Vasomotor instability Coronary artery disease Epilepsy Parkinsonism Side Effects: Early signs of overdosage are abdominal discomfort, blurred vision, salivation, flushing of the skin (hot feeling), sweating, nausea and vomiting ( SLUDE-like symptoms ) 2) , bronchoconstriction, increased stomach acid secretion, hypotension
The increased bone formation was attributed to larger bone dimensions and increased cortical cross-sectional area, as determined by in vitro measurements with peripheral quantitative computed tomography (pQCT) and Archimedes' principle
